Inhibition of DNA repair is considered a promising approach to improve the sensitivity of cancer cells to IR, thus, different DNA repair enzymes have been validated as therapeutic targets for radiosensitization in various cancers (15–22). This evidence concerns the gene LIG4 and cancer.